Phibro Animal Health Corporation revised earnings guidance for the fiscal year ending June 30, 2023. For the year, the company expects net sales of $960 million - $1 billion (unchanged); net income of $34 million- $38 million, from $39 million- $43 million; diluted EPS of $0.84 - $0.94, from $0.96 - $1.06.